[1]
T. Jurca, “Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-cell recovery”, Radiol Oncol, vol. 60, no. 1, pp. 76–85, Mar. 2026.